Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
for Breast Cancer
15 locations incl. Stamford
Sponsor: Dana-Farber Cancer Institute
Sex: All·Age: 18+
Code: NCT04468061·Phase 2·Recruiting·Listed Jul 2020
Clinical research site in Chattanooga, Tennessee
Part of Sarah Cannon Research Institute
As of July 2026, 1 paid clinical trial is recruiting at Sarah Cannon Research Institute in Chattanooga, Tennessee. Active studies at this site cover conditions such as Breast Cancer, Triple Negative Breast Cancer and PD-L1 Negative. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Paid clinical trials in Chattanooga, TN · Tennessee clinical trials